Travelling abroad for rehabilitation may help some patients gain access to particular physicians, services, languages, timetables, or environments, but it does not automatically make the care more intensive, better coordinated, more advanced, cheaper, or more effective than at home. The benefit must be weighed against the interruption of the existing services, the stress of travel, complications while far from the existing team, obstacles to access, and the difficulty of continuing the care after returning.

This list is for those who are considering rehabilitation in Thailand. It does not recommend a destination or a provider, and it cannot judge whether any individual is ready to travel.

Begin from the clinical needs and the alternatives available

Identify the problem you want to solve by travelling, such as wanting a specialist physician's opinion, a multidisciplinary assessment, a short trial of therapy, training a carer, ordering equipment, inpatient rehabilitation, or long-term support in the community. Compare the local, regional, remote, and overseas alternatives realistically. Distance or technology should not be taken to indicate quality.

The home physician and the destination team should review medical stability, the current function, the possible benefit, the risk from the interruption, and the level of medicine and nursing that the destination must have. Treatment abroad should be voluntary. A discount, pressure from the family, or the design of a package should not limit the choices that are clinically suitable.

The outcome cannot be predicted from the diagnosis, the intensity, the equipment, or the length of stay alone. It should be asked what evidence supports the approach for this state, how a meaningful result will be measured, and what would make the plan change or stop.

Review readiness to travel before paying

The CDC advises those with chronic disease to receive a pre-travel assessment before buying travel that is non-refundable, and this should be done 4–6 weeks before departure if possible. A recent cerebrovascular event, surgery, hospital admission, or seizures, heart or lung disease, diabetes, infection, wounds, a need for oxygen, a history of blood clots, pregnancy, and great limitations of movement or thinking may change the timing, the method, the support, or the safety.

The treating physician can give advice, but the airline may have its own process of medical clearance. Oxygen, batteries, mobility equipment, lifting, seating, toilets, carrying medicines, and companions must be confirmed with the airline directly. Do not assume that a fitness-to-fly letter guarantees boarding, or that the cabin crew can give personal care or nursing.

Travel longer than 4 hours may increase the risk of blood clots, particularly after recent surgery, when movement is limited, with cancer, with previous blood clots, in pregnancy, or with other factors. Prevention must be adjusted to the individual. Aspirin or anticoagulants should not be started by yourself. Sudden difficulty breathing, chest pain, coughing blood, fainting, or swelling of one limb must receive an urgent assessment.

Check the provider and the scope without relying on marketing

Ask for answers in writing and check them independently where possible:

Who is clinically responsible, and are the professional licence and the specialist qualifications still valid
Is the facility licensed for outpatients, inpatients, nursing, procedures, or emergencies as proposed
Which experts will assess and treat, and how much direct contact is planned
What evidence supports the treatment, and which parts are experimental or optional extras
How are adverse events, infections, falls, medication errors, patient protection, and complaints managed
What staffing is there outside therapy hours
Which hospital receives emergencies, how is a transfer called, and who accompanies the patient
Is there outcome data, infection control standards, accreditation, and safety processes available to check

Accreditation can be one signal, but it does not guarantee that a particular programme is suitable or that complications will not arise. Testimonials from users, luxurious accommodation, "advanced" equipment, and a large number of sessions do not replace clinical governance and transparent outcomes.

Before making an agreement, the patient should receive information that can be understood about the diagnosis or the uncertainties, the assessment and the treatment, the alternatives, the burden, the important risks, the length of time expected, the limitations of the evidence, the costs, the conditions for refunds, and the follow-up. Consent is a continuing choice, not a signature attached to a package.

There should be a professional interpreter for clinical conversations when necessary. Relatives can give support but should not be the main interpreter for consent, sensitive information, or complex risks. It should be asked whether the documents, the prescriptions, the exercise instructions, and the discharge summary will be in a language and a format that the patient and the home team can use.

The rules of privacy, the ways of complaining, compensation, and legal proceedings may differ between countries. The permissions and the storage of medical records, photographs, videos, and news for the family must be made clear, together with contact details for privacy or patient protection.

Check accessibility throughout the journey

The words "wheelchair accessible" are not detailed enough. The needs of the individual must be compared against the airport, the aircraft, the transport, the accommodation, the clinic, the examination room, the toilet, the shower, the bed, the fire escape, and the surrounding area.

Check the dimensions, the slopes, the steps, the reliability of the lift, the transfer equipment, the hoist, the reduction of pressure, the securing of the wheelchair in the vehicle, the backup lighting, the socket standards, the communication devices, the quiet spaces, the signage, the sensory needs, and the help at night. Confirm who is responsible when mobility equipment is delayed or damaged, and whether there is an equivalent replacement.

The carer must also receive an assessment and a plan. Define the tasks that must be trained, what one person can do safely, having someone to help with lifting, rest periods, and who takes over when the carer is ill.

Plan the medicines, the prevention of infection, and the equipment

Bring enough regular medicine for the whole journey, together with a reserve, in the original labelled packaging. Use generic names and a schedule that takes account of the time zones. Keep the important medicines, medical supplies, documents, and chargers in the hand luggage. Check the restrictions on controlled medicines at the destination, and do not expect to be able to find the same brand.

Consult about general and destination-specific vaccines, the risk of infection, the latest drug-resistant organisms, wounds, urinary catheters or feeding tubes, and the management of fever or diarrhoea. Treatment abroad may expose one to patterns of drug resistance different from those at home. If an infection arises after returning, the doctor should be told about all the services received abroad.

Equipment ordered from abroad must be usable at home. Before buying, the dimensions, the maintenance, the consumables, the warranty, the software, the electrical system, the repairs, and the ability of the local team to care for it safely should be confirmed.

Create an emergency and financial plan

Identify the emergency numbers, the hospital, the ambulance, the decision-maker, the contact for the home team, and who is responsible for communication and payment. The plan should cover deterioration, hospital admission, intensive care, a longer stay, missed flights, a carer falling ill, death, repatriation, and medical evacuation.

Check an itemised estimate. Make clear the costs of assessment, professional fees, medicines, tests, equipment, interpreters, travel, accommodation, carers, cancellation, early discharge, complications, and follow-up. Travel insurance usually excludes pre-existing disease and planned treatment. Medical and evacuation cover, the exclusions, prior approval, and direct payment must be confirmed specifically.

Protect continuity before, during, and after the journey

The home team should know the purpose and the timing of the journey, and communicate directly with the destination team when the patient consents. Agree who is responsible for the medicines, the follow-up, urgent questions, and decisions while the patient is between two systems.

Before returning, complete documents should be received in a language and a format that can be used, namely the assessment, the diagnosis, the procedures, the medicines, adverse events, test results and images, infection information, the current function, the precautions, the equipment, the outcome measures, and the follow-up. A summary alone may not be enough when a complication arises.

The first local follow-up appointment should be arranged before leaving the destination. If the overseas team offers remote follow-up, the limitations, the licence, the time zones, privacy, the costs, and the route of referral must be confirmed. Remote consultation does not replace examination in the area or emergency services.

A balanced decision

Rehabilitation abroad may be reasonable when the purpose is clear, the patient is ready to travel, the service is suitable and can be checked, the consent is meaningful, the needs for access are met, the risks and the costs are understood, and continuity is assured. It may not be suitable when the condition is not stable, there is no acute care, the travel interferes with necessary treatment, the results promised are exaggerated, or the treatment cannot be continued.

The suitable comparison is not "Thailand against home", but whether each alternative can meet the current needs and the long-term goals of this particular patient safely.